RE:RE:RE:RE:Pathways to $10+ So we've got some opinions based on overall population sentiment on vaccines. Anyone want to chime in on fundamentals? Current book value on CPA Jazz segment valued ~3.8-$4, with CAC at less than .50c. With current forward PE of 7.5... we were trading high $7s with a 9x forward PE in '17-18, when CHR got a large infusion from faitfax to supplement CAC.
CAC is the "blue sky/ dark horse" and we need mgmt to actively pursue repurposing those dash 8s. Hoping to see some substantial news, unfortunately leasing out 3,4 of them won't cut it in the grand scheme of things.
looking for other insights, maybe some more substance instead of the whole vaccine argument...